These bioactivities include inhibition activity against the following enzymes: dipeptidyl peptidase III (DPP-III), related to cancer and inflammation; dipeptidyl peptidase IV (DPP-IV), associated with type 2 diabetes; the angiotensin-converting enzyme (ACE), related to hypertension; and α-glucosidase, related to diabetes. Here, ACE is linked to diabetes mellitus.